JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenzel-Seifert, K.
Right arrow Articles by Seifert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel-Seifert, K.
Right arrow Articles by Seifert, R.

Vol. 299, Issue 3, 1013-1020, December 2001

Similar Apparent Constitutive Activity of Human Histamine H2-Receptor Fused to Long and Short Splice Variants of Gsalpha

Katharina Wenzel-Seifert, Melissa T. Kelley1 , Armin Buschauer and Roland Seifert

Department of Pharmacology and Toxicology, the University of Kansas, Lawrence, Kansas (K.W.-S., M.T.K., R.S.); and Department of Pharmacy, University of Regensburg, Regensburg, Germany (A.B.)

Fusion proteins allow for the analysis of receptor/G protein coupling under defined conditions. The beta 2-adrenoceptor (beta 2AR) fused to the long splice variant of Gsalpha (Gsalpha L) exhibits a higher apparent constitutive activity than the beta 2-adrenoceptor fused to the short splice variant of Gsalpha (Gsalpha S). Experimentally, this results in higher efficacy and potency of partial agonists and in higher efficacy of inverse agonists at the beta 2AR fused to Gsalpha L relative to the beta 2AR fused to Gsalpha S, indicating that the agonist-free beta 2AR and the beta 2AR occupied by partial agonists promote GDP dissociation from Gsalpha L more efficiently than from Gsalpha S. In fact, the GDP affinity of Gsalpha S fused to the beta 2AR is higher than the GDP affinity of Gsalpha L fused to the beta 2AR. We asked the question whether the histamine H2-receptor (H2R) exhibits similar coupling to Gsalpha splice variants as the beta 2AR. To address this question, we studied H2R-Gsalpha fusion proteins expressed in Sf9 cells. In contrast to beta 2AR-Gsalpha fusion proteins, the potencies and efficacies of partial agonists and the efficacies of inverse agonists were similar at the H2R fused to Gsalpha L and Gsalpha S as assessed by guanosine-5'-O-(3-thio)triphosphate binding and/or steady-state GTPase activity. However, the time course analysis of guanosine-5'-O-(3-thio)triphosphate binding indicated that Gsalpha S fused to the H2R possesses a higher GDP-affinity than Gsalpha L fused to the H2R. Our data show that the H2R fused to Gsalpha L and Gsalpha S possesses similar constitutive activity and is insensitive to differences in GDP affinity of Gsalpha splice variants. Thus, GDP affinity of G proteins does not generally determine constitutive activity of receptors.


1 Current address: Quintiles Inc., Kansas City, MO 64134.


0022-3565/01/2993-1013$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. I. Kaya, O. Ugur, S. S. Oner, M. Bastepe, and H. O. Onaran
Coupling of {beta}2-Adrenoceptors to XL{alpha}s and G{alpha}s: A New Insight into Ligand-Induced G Protein Activation
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 350 - 359.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Weitl and R. Seifert
Distinct Interactions of Human {beta}1- and {beta}2-Adrenoceptors with Isoproterenol, Epinephrine, Norepinephrine, and Dopamine
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 760 - 769.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-X. Xie, A. Kraus, P. Ghorai, Q.-Z. Ye, S. Elz, A. Buschauer, and R. Seifert
N1-(3-Cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a Potent Partial Agonist for the Human Histamine H1- and H2-Receptors
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1262 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S.-X. Xie, P. Ghorai, Q.-Z. Ye, A. Buschauer, and R. Seifert
Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 139 - 146.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.